| Literature DB >> 27863480 |
Ying Zhang1,2, Songli Mei3, Rui Yang4, Ling Chen4, Hang Gao4, Li Li5.
Abstract
BACKGROUND: Cardio-metabolic syndrome (CMS) is a highly prevalent condition. There is an urgent need to identify effective and integrated multi-disciplinary approaches that can reduce risk factors for CMS.Entities:
Keywords: Cardio-metabolic syndrome; China; Cognitive behavioral therapy; Patient-centered; Randomised controlled trial
Mesh:
Year: 2016 PMID: 27863480 PMCID: PMC5116154 DOI: 10.1186/s12872-016-0398-9
Source DB: PubMed Journal: BMC Cardiovasc Disord ISSN: 1471-2261 Impact factor: 2.298
Components of PC-CBT lifestyle intervention
| Workshop curriculum modules | Subjects |
|---|---|
| Module 1: break ice | Welcome, introduce each other, subjects overview |
| Module 2: interaction with each other deeply | Acquaintance each other, talking about their own families, work if have one, tailoring communication to preferences, needs and values, discussing differences |
| Module 3: talking about health | Communication about CMS, challenge and opportunities, sharing of illness related fears and concerns, risk assessment |
| Module 4: talking about lifestyle | Methods in health regulation, exercise, eating habit, and so on |
| Module 5: methods in psychology adjustment | CBT, behavioral reinforcement, meditation, stress management, and abdominal breathing |
| Module 6: patient-centered | Shared-clinical decision-making scheme, self-deterrnination theory, participant attitude, awareness of being responsible for their own health |
| Module 7: viable lifestyle change program | Reasonable diet and exercise, don’t stay up late, eliminate smoking, limit alcohol consumption, night-time snack eating habits |
| Module 8: close | Planning of personal goal, close |
Note: CMS cardio-metabolic syndrome, PC-CBT patient-centered cognitive behavioral therapy
Fig. 1Detailed flow of participants through the study
Raw data by group and P-value at baseline point and the end of intervention
| Baseline characteristics | The end of intervention | |||||||
|---|---|---|---|---|---|---|---|---|
| (week 0) | (week 12) | |||||||
| All subjects | Control | Intervention |
| Control | Intervention | mean diff.(95% CI) |
| |
| Not smoking (N, %) | 18(60) | 16(57.1) | 22(73.3) | 24(85.7) | ||||
| Saturated fat(≤10% of total energy)(N, %) | 14(46.7) | 13(46.4) | 18(60) | 23(82.1) | ||||
| Fruit and vegetables(≥400 g per day)(N, %) | 9(30) | 10(35.7) | 13(43.3) | 22(78.6) | ||||
| Physical activity(≥150 min per week)(N, %) | 11(36.7) | 11(39.3) | 16(53.3) | 20(71.4) | ||||
| WC total (cm) | 94.2 ± 3.2 | 94.9 ± 2.8 | 93.4 ± 3.4 | 0.071 | 94.1 ± 2.8 | 86.0 ± 2.4 | −8.1 (−9.5, −6.7) | .000*** |
| WC in men | — | 96 ± 2.4 | 94.6 ± 3.9 | 0.215 | 95.2 ± 2.4 | 87.3 ± 2.3 | −7.9 (−9.6, −6.2) | .000*** |
| WC in women | — | 93 ± 2.5 | 92 ± 2.3 | 0.212 | 92.5 ± 2.8 | 84.5 ± 1.6 | −8.0 (−9.9, −6.2) | .000*** |
| Cardio-metabolic | ||||||||
| TG (mmol/L) | 2.0 ± 0.4 | 2.1 ± 0.2 | 1.9 ± 0.5 | 0.127 | 1.9 ± 0.2 | 1.1 ± 0.3 | −0.8 (−0.9, −0.7) | .000*** |
| RSBP (mmHg) | 140.5 ± 3.4 | 140.0 ± 3.2 | 141.5 ± 3.3 | 0.032 | 137.9 ± 3.2 | 134.5 ± 3.7 | −3.4 (−5.2, −1.6) | .000*** |
| Quality of life | ||||||||
| SF-36 total | 419.3 ± 112.4 | 409.8 ± 87.5 | 414.6 ± 116.8 | 0.764 | 530.1 ± 95.6 | 637.2 ± 58.2 | 107.1 (65.6, 148.1) | .000*** |
| MH | 48.1 ± 17.3 | 49.9 ± 17.6 | 46.1 ± 17.0 | 0.416 | 63.9 ± 16.6 | 69.9 ± 13.0 | 6.0 (−1.9, 13.9) | 0.133 |
| RE | 46.6 ± 25.7 | 43.3 ± 27.9 | 50.0 ± 23.2 | 0.328 | 62.2 ± 24.4 | 77.4 ± 15.8 | 15.2 (4.3, 26.1) | .007** |
| PF | 48.8 ± 12.6 | 49.7 ± 12.7 | 47.9 ± 12.6 | 0.588 | 61.5 ± 13.3 | 79.0 ± 13.8 | 17.4 (10.3, 24.6) | .000*** |
| RP | 47.8 ± 27.0 | 47.5 ± 28.1 | 48.2 ± 26.3 | 0.921 | 61.7 ± 26.9 | 81.2 ± 14.6 | 19.6 (8.2, 30.9) | .001** |
| BP | 55.2 ± 20.0 | 55.2 ± 22.0 | 55.1 ± 17.9 | 0.974 | 68.6 ± 20.7 | 82.0 ± 12.8 | 13.3 (4.3, 22.3) | .000*** |
| SF | 60.3 ± 15.4 | 57.5 ± 14.2 | 63.4 ± 16.3 | 0.146 | 70.8 ± 13.7 | 87.1 ± 8.7 | 16.2 (10.2, 22.2) | .000*** |
| VT | 57.7 ± 18.9 | 61.7 ± 18.0 | 53.4 ± 19.2 | 0.096 | 76.7 ± 15.1 | 80.4 ± 11.5 | 3.7 (−3.4, 10.8) | 0.303 |
| GH | 54.8 ± 19.2 | 58.8 ± 16.7 | 50.5 ± 21.1 | 0.101 | 64.7 ± 18.2 | 80.4 ± 10.8 | 15.7 (7.9, 23.5) | .000*** |
| Obese (N, %) | ||||||||
| hypertension (N, %) | 21 (70) | 16 (57.1) | 21 (70) | 9 (32.1) | ||||
| hypertriglyceridemia | 13 (43.3) | 19 (67.9) | 10 (33.3) | 2 (7.1) | ||||
| (N, %) | 4 (13.3) | 3 (10.7) | 2 (6.7) | 0 (0) | ||||
Note: Continuous variables are summarized by mean ± SD. Categorical variables are reported as N (%).*** significantly different (P < 0.001). ** significantly different (P < 0.01)
Abbreviations: WC waist circumference, TG fasting serum-triglycerides, RSBP resting systolic blood tension, SF social functioning, MH mental health, RE role-emotional, PF physical functioning, RP role –physical, BP bodily pain, VT vitality, GH general health
The post – intervention analyses based on GLM(n = 58)
| Outcome variable | Test of between-subjects effects | Parameter estimates | |||
|---|---|---|---|---|---|
| 95% CI | |||||
| F |
| B | Lower | Upper | |
| WC total a | 35.960 | 0.000 | 0.535 | 0.357 | 0.714 |
| TG (mmol/L) b | 18.925 | 0.000 | 0.378 | 0.204 | 0.552 |
| RSBP (mmHg) c | 33.888 | 0.000 | 0.647 | 0.424 | 0.869 |
| SF-36 total d | 157.932 | 0.000 | 0.607 | 0.510 | 0.703 |
Note: Age, education were examined separately and were not significant
a: Independent variable: pre WC
b: Independent variable: pre TG
c: Independent variable: pre RSBP
d: Independent variable: pre SF-36 total
GLM general linear model
WC waist circumference
TG fasting serum-triglycerides
RSBP resting systolic blood tension
SF social functioning
Fig. 2Mean Waist circumference (WC) of men between two groups
Fig. 3Mean Waist circumference (WC) of women between two groups